Loading clinical trials...
Loading clinical trials...
Assessment of Participant Adherence and Glucose Control While Using a Connected Insulin Management Platform
Conditions
Interventions
Insulin Lispro
Tempo Smart Button
+2 more
Locations
9
France
CHU Strasbourg-Hautepierre
Strasbourg, Alsace, France
CHU de Caen Hôpital Cote de Nacre
Caen, Cedex 9, France
CHU de Besancon Hopital Jean Minjoz
Besançon, France
Centre Hospitalier Sud Francilien-Pharmacie
Corbeil-Essonnes, France
Chu de Grenoble
Grenoble Cédex 9, France
CHU de Lyon
Lyon, France
Start Date
October 5, 2023
Primary Completion Date
September 16, 2024
Completion Date
September 16, 2024
Last Updated
November 10, 2025
NCT07224321
NCT07395050
NCT07457580
NCT07232537
NCT06815081
NCT06474598
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions